Clinical Trials Logo

Clinical Trial Summary

For twin pregnancies at 32-38 weeks gestation, where twin A is head down, does a policy of planned caesarean section (CS) lower the likelihood of death or serious illness, during the first 28 days after birth, compared to a plan for vaginal birth (VB)?


Clinical Trial Description

For twin pregnancies of 32-38 weeks gestation, where twin A is presenting cephalic, does a policy of planned CS decrease the likelihood of perinatal or neonatal mortality or serious neonatal morbidity, during the first 28 days after birth, compared to a policy of planned VB? ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00187369
Study type Interventional
Source Sunnybrook Health Sciences Centre
Contact
Status Completed
Phase N/A
Start date December 2003
Completion date October 2011

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04588597 - Obstetric and Neonatal Outcomes of Twin Pregnancy
Recruiting NCT04051567 - Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies Phase 4
Terminated NCT03863613 - Pessary Versus Cerclage With or Without Progesterone in Twins N/A
Completed NCT00502190 - Evaluation Of Pessaries In Twin Pregnancies With A Short Cervix (25 mm) Between 20-28 WG (EPEGE) Phase 3
Completed NCT04353856 - Quality of Life During a Twin Pregnancy
Recruiting NCT05727085 - Cohort of Twin Pregnancy and the Offspring
Completed NCT04232436 - Planned Vaginal Delivery vs Planned Cesarean Delivery in Preterm Twins
Completed NCT05104255 - Neonatal Outcomes in Twin Pregnancies
Withdrawn NCT03540225 - Vaginal Progesterone for the Prevention of Preterm Birth in Twins Phase 3